Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 11,250 shares at $385.00 ($4.3M) on 2023-11-06, disclosed to the SEC on 2023-11-08.
Scheduled sale ($4.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2024-05-24 | $3.2M | — | Filing → |
| VRTX | SELL | 2023-07-18 | $8.0M | — | Filing → |
| VRTX | SELL | 2023-04-14 | $13.9M | — | Filing → |